# Frequency Electronics Inc: financial statements, quarterly

FEIM · Nasdaq · CIK 39020 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/feim.md) · [Financials](/companies/feim/financials.md) · [Filings](/companies/feim/filings.md) · [Insiders](/companies/feim/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/feim/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.6](/filings/0001185185-24-001209.md) | [13.7](/filings/0001185185-25-000189.md) | [15.6 d](/filings/0001185185-25-000806.md) | [15.1](/filings/0001185185-25-001203.md) | [15.8](/filings/0001185185-25-002057.md) | [18.9](/filings/0001185185-26-000893.md) | [20.0 d](/filings/0001185185-26-002997.md) | [13.8](/filings/0001185185-26-003983.md) | [17.1](/filings/0001185185-25-002057.md) | [16.9](/filings/0001185185-26-000893.md) | [15.4 d](/filings/0001185185-26-002997.md) | [23.5](/filings/0001185185-26-003983.md) |
| Cost of revenue | $m | [9.2](/filings/0001185185-24-001209.md) | [10.6](/filings/0001185185-25-000189.md) | [9.3 d](/filings/0001185185-25-000806.md) | [8.4](/filings/0001185185-25-001203.md) | [8.2](/filings/0001185185-25-002057.md) | [10.6](/filings/0001185185-26-000893.md) | [12.5 d](/filings/0001185185-26-002997.md) | [8.7](/filings/0001185185-26-003983.md) | [10.6](/filings/0001185185-25-002057.md) | [10.3](/filings/0001185185-26-000893.md) | [15.2 d](/filings/0001185185-26-002997.md) | [12.7](/filings/0001185185-26-003983.md) |
| Gross profit | $m | [4.3](/filings/0001185185-24-001209.md) | [3.1](/filings/0001185185-25-000189.md) | [6.3 d](/filings/0001185185-25-000806.md) | [6.7](/filings/0001185185-25-001203.md) | [7.6](/filings/0001185185-25-002057.md) | [8.3](/filings/0001185185-26-000893.md) | [7.5 d](/filings/0001185185-26-002997.md) | [5.1](/filings/0001185185-26-003983.md) | [6.5](/filings/0001185185-25-002057.md) | [6.6](/filings/0001185185-26-000893.md) | [0.2 d](/filings/0001185185-26-002997.md) | [10.8](/filings/0001185185-26-003983.md) |
| Research and development | $m | [0.8](/filings/0001185185-24-001209.md) | [1.0](/filings/0001185185-25-000189.md) | [1.1 d](/filings/0001185185-25-000806.md) | [1.5](/filings/0001185185-25-001203.md) | [1.6](/filings/0001185185-25-002057.md) | [1.4](/filings/0001185185-26-000893.md) | [1.5 d](/filings/0001185185-26-002997.md) | [1.1](/filings/0001185185-26-003983.md) | [1.2](/filings/0001185185-25-002057.md) | [1.8](/filings/0001185185-26-000893.md) | [1.9 d](/filings/0001185185-26-002997.md) | [1.4](/filings/0001185185-26-003983.md) |
| Selling, general and administrative | $m | [2.6](/filings/0001185185-24-001209.md) | [2.6](/filings/0001185185-25-000189.md) | [2.7 d](/filings/0001185185-25-000806.md) | [2.8](/filings/0001185185-25-001203.md) | [3.4](/filings/0001185185-25-002057.md) | [3.4](/filings/0001185185-26-000893.md) | [2.7 d](/filings/0001185185-26-002997.md) | [3.6](/filings/0001185185-26-003983.md) | [3.6](/filings/0001185185-25-002057.md) | [3.6](/filings/0001185185-26-000893.md) | [4.6 d](/filings/0001185185-26-002997.md) | [4.1](/filings/0001185185-26-003983.md) |
| Operating income | $m | [0.9](/filings/0001185185-24-001209.md) | [(0.5)](/filings/0001185185-25-000189.md) | [2.5 d](/filings/0001185185-25-000806.md) | [2.4](/filings/0001185185-25-001203.md) | [2.6](/filings/0001185185-25-002057.md) | [3.5](/filings/0001185185-26-000893.md) | [3.3 d](/filings/0001185185-26-002997.md) | [0.4](/filings/0001185185-26-003983.md) | [1.7](/filings/0001185185-25-002057.md) | [1.3](/filings/0001185185-26-000893.md) | [(6.4) d](/filings/0001185185-26-002997.md) | [5.2](/filings/0001185185-26-003983.md) |
| Interest expense | $m | [0.0](/filings/0001185185-24-001209.md) | [0.0](/filings/0001185185-25-000189.md) | [0.0 d](/filings/0001185185-25-000806.md) | [0.0](/filings/0001185185-25-001203.md) | [0.0](/filings/0001185185-25-002057.md) | [0.0](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | [0.0](/filings/0001185185-26-003983.md) | [0.0](/filings/0001185185-25-002057.md) | [0.0](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | [0.0](/filings/0001185185-26-003983.md) |
| Income tax | $m | [0.0](/filings/0001185185-24-001209.md) | [0.0](/filings/0001185185-25-000189.md) | [(0.1) d](/filings/0001185185-25-000806.md) | [0.1](/filings/0001185185-25-001203.md) | [0.1](/filings/0001185185-25-002057.md) | [(11.8)](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | [(0.1)](/filings/0001185185-26-003983.md) | [(0.0)](/filings/0001185185-25-002057.md) | [(0.1)](/filings/0001185185-26-000893.md) | [(1.8) d](/filings/0001185185-26-002997.md) | [1.0](/filings/0001185185-26-003983.md) |
| Net income | $m | [0.8](/filings/0001185185-25-000189.md) | [0.1](/filings/0001185185-25-000189.md) | [2.6 d](/filings/0001185185-25-000806.md) | [2.4](/filings/0001185185-26-000893.md) | [2.7](/filings/0001185185-26-000893.md) | [15.4](/filings/0001185185-26-000893.md) | [3.2 d](/filings/0001185185-26-002997.md) | [0.6](/filings/0001185185-26-003983.md) | [1.8](/filings/0001185185-26-000893.md) | [1.6](/filings/0001185185-26-000893.md) | [(4.9) d](/filings/0001185185-26-002997.md) | [4.2](/filings/0001185185-26-003983.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001185185-24-001209.md) | [0.01](/filings/0001185185-25-000189.md) | not reported | [0.25](/filings/0001185185-25-001203.md) | [0.28](/filings/0001185185-25-002057.md) | [1.60](/filings/0001185185-26-000893.md) | not reported | [0.07](/filings/0001185185-26-003983.md) | [0.18](/filings/0001185185-25-002057.md) | [0.16](/filings/0001185185-26-000893.md) | not reported | [0.41](/filings/0001185185-26-003983.md) |
| Basic EPS | $ per share | [0.08](/filings/0001185185-24-001209.md) | [0.01](/filings/0001185185-25-000189.md) | not reported | [0.25](/filings/0001185185-25-001203.md) | [0.28](/filings/0001185185-25-002057.md) | [1.60](/filings/0001185185-26-000893.md) | not reported | [0.07](/filings/0001185185-26-003983.md) | [0.18](/filings/0001185185-25-002057.md) | [0.16](/filings/0001185185-26-000893.md) | not reported | [0.41](/filings/0001185185-26-003983.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.7](/filings/0001185185-23-001307.md) | [11.7](/filings/0001185185-24-000269.md) | [18.3](/filings/0001185185-25-000806.md) | [16.2](/filings/0001185185-24-000882.md) | [9.7](/filings/0001185185-24-001209.md) | [5.5](/filings/0001185185-25-000189.md) | [4.7](/filings/0001185185-26-002997.md) | [4.5](/filings/0001185185-25-001203.md) | [3.0](/filings/0001185185-25-002057.md) | [0.1](/filings/0001185185-26-000893.md) | [1.6](/filings/0001185185-26-003983.md) | [61.4](/filings/0001185185-26-003983.md) |
| Current assets | $m | [49.7](/filings/0001185185-23-001307.md) | [52.1](/filings/0001185185-24-000269.md) | [58.1](/filings/0001185185-25-000806.md) | [59.2](/filings/0001185185-24-000882.md) | [52.9](/filings/0001185185-24-001209.md) | [50.1](/filings/0001185185-25-000189.md) | [53.1](/filings/0001185185-26-002997.md) | [52.3](/filings/0001185185-25-001203.md) | [50.9](/filings/0001185185-25-002057.md) | [52.6](/filings/0001185185-26-000893.md) | [48.0](/filings/0001185185-26-003983.md) | [111](/filings/0001185185-26-003983.md) |
| Total assets | $m | [74.7](/filings/0001185185-23-001307.md) | [77.7](/filings/0001185185-24-000269.md) | [83.3](/filings/0001185185-25-000806.md) | [84.3](/filings/0001185185-24-000882.md) | [77.8](/filings/0001185185-24-001209.md) | [86.4](/filings/0001185185-25-000189.md) | [93.7](/filings/0001185185-26-002997.md) | [93.2](/filings/0001185185-25-001203.md) | [92.3](/filings/0001185185-25-002057.md) | [94.2](/filings/0001185185-26-000893.md) | [90.7](/filings/0001185185-26-003983.md) | [154](/filings/0001185185-26-003983.md) |
| Current liabilities | $m | [25.0](/filings/0001185185-23-001307.md) | [28.0](/filings/0001185185-24-000269.md) | [30.8](/filings/0001185185-25-000806.md) | [38.7](/filings/0001185185-24-000882.md) | [29.5](/filings/0001185185-24-001209.md) | [22.9](/filings/0001185185-25-000189.md) | [23.5](/filings/0001185185-26-002997.md) | [22.7](/filings/0001185185-25-001203.md) | [19.7](/filings/0001185185-25-002057.md) | [20.2](/filings/0001185185-26-000893.md) | [21.0](/filings/0001185185-26-003983.md) | [20.8](/filings/0001185185-26-003983.md) |
| Total liabilities | $m | [38.5](/filings/0001185185-23-001307.md) | [41.1](/filings/0001185185-24-000269.md) | [43.4](/filings/0001185185-25-000806.md) | [51.1](/filings/0001185185-24-000882.md) | [41.6](/filings/0001185185-24-001209.md) | [34.6](/filings/0001185185-25-000189.md) | [38.1](/filings/0001185185-26-002997.md) | [36.9](/filings/0001185185-25-001203.md) | [33.8](/filings/0001185185-25-002057.md) | [33.9](/filings/0001185185-26-000893.md) | [34.3](/filings/0001185185-26-003983.md) | [33.7](/filings/0001185185-26-003983.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [36.3](/filings/0001185185-25-000189.md) | [36.7](/filings/0001185185-25-000189.md) | [39.8](/filings/0001185185-26-002997.md) | [33.2](/filings/0001185185-26-000893.md) | [36.2](/filings/0001185185-26-000893.md) | [51.8](/filings/0001185185-26-000893.md) | [55.6](/filings/0001185185-26-003983.md) | [56.3](/filings/0001185185-26-003983.md) | [58.5](/filings/0001185185-26-000893.md) | [60.2](/filings/0001185185-26-000893.md) | [56.4](/filings/0001185185-26-003983.md) | [120](/filings/0001185185-26-003983.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(180) d](/filings/0001185185-24-001209.md) | [4,207 d](/filings/0001185185-25-000189.md) | [7,482 d](/filings/0001185185-25-000806.md) | [(1,458)](/filings/0001185185-25-001203.md) | [3,810 d](/filings/0001185185-25-002057.md) | [(3,625) d](/filings/0001185185-26-000893.md) | [(155) d](/filings/0001185185-26-002997.md) | [1,161](/filings/0001185185-26-003983.md) | [(523) d](/filings/0001185185-25-002057.md) | [(1,417) d](/filings/0001185185-26-000893.md) | [2,061 d](/filings/0001185185-26-002997.md) | [2,622](/filings/0001185185-26-003983.md) |
| Capital expenditure | $k | [173 d](/filings/0001185185-24-001209.md) | [311 d](/filings/0001185185-25-000189.md) | [821 d](/filings/0001185185-25-000806.md) | [327](/filings/0001185185-25-001203.md) | [521 d](/filings/0001185185-25-002057.md) | [329 d](/filings/0001185185-26-000893.md) | [631 d](/filings/0001185185-26-002997.md) | [776](/filings/0001185185-26-003983.md) | [613 d](/filings/0001185185-25-002057.md) | [865 d](/filings/0001185185-26-000893.md) | [605 d](/filings/0001185185-26-002997.md) | [844](/filings/0001185185-26-003983.md) |
| Dividends paid | $k | not reported | [0.0 d](/filings/0001185185-25-000189.md) | [0.0 d](/filings/0001185185-25-000806.md) | not reported | [9,567](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | not reported | not reported | [0.0 d](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | not reported |
| Share repurchases | $k | not reported | [0.0 d](/filings/0001185185-25-000189.md) | [0.0 d](/filings/0001185185-25-000806.md) | [62.0](/filings/0001185185-25-001203.md) | [100 d](/filings/0001185185-25-002057.md) | [215 d](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | [583](/filings/0001185185-26-003983.md) | [375 d](/filings/0001185185-25-002057.md) | [616 d](/filings/0001185185-26-000893.md) | [0.0 d](/filings/0001185185-26-002997.md) | [0.0](/filings/0001185185-26-003983.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.3](/filings/0001185185-23-001307.md) | [9.3](/filings/0001185185-24-000269.md) | [9.4](/filings/0001185185-24-000882.md) | [9.4](/filings/0001185185-24-001209.md) | [9.4](/filings/0001185185-25-000189.md) | [9.5](/filings/0001185185-25-001203.md) | [9.6](/filings/0001185185-25-002057.md) | [9.6](/filings/0001185185-26-000893.md) | [9.7](/filings/0001185185-26-003983.md) | [9.8](/filings/0001185185-25-002057.md) | [9.8](/filings/0001185185-26-000893.md) | [10.2](/filings/0001185185-26-003983.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,273,287 at 2026-09-08, from the cover of the [10-Q filed 2026-09-14](/filings/0001185185-26-003983.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.